DealStreetAsia
India's Biocon Biologics in funding talks with Baring PE Asia
Country's largest biopharmaceutical eyes valuation of over $100m
Pharmaceuticals
COVID vaccines
U.S. FDA advisers back COVID shots for children under 5
Officials in U.S. report 442 coronavirus deaths in young children so far
Climate Change
Takeda teams with GSK, other drugmakers to help cut supplier emissions
Over 1,000 vendors show interest in common system to estimate greenhouse gases
COVID vaccines
Shionogi to file as soon as June for COVID shot green light
Homegrown vaccine developers inch closer to rollouts in Japan
Electronics
Samsung to invest $356bn over five years in strategic sectors
South Korean conglomerate targets long-term growth in chips, biopharmaceuticals
Pharmaceuticals
Indonesia's top drugmaker Kalbe Farma to boost ASEAN expansion
Philippine venture 'first step,' executive says, with Middle East on the horizon
Business deals
Ricoh jumps into mRNA pharmaceuticals with U.S. startup deal
Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025
Pharmaceuticals
Nichi-Iko Pharma seeks debt restructuring aided by white knight
Scandal-hit Japan drugmaker opts for alternative dispute model
Pharmaceuticals
Japanese drugmakers reduce Russia business in wake of Ukraine war
They join global peers in pulling back as logistics, payment systems deteriorate
COVID vaccines
Japan pharma cranks up output of COVID vaccine materials
Global supplies shortage and dependence on West spell urgency, opportunity
Pharmaceuticals
Biogen CEO to step down as Eisai partner pulls back on Alzheimer's drug
Aduhelm was expected to be the company's next blockbuster but has faced doubts
Pharmaceuticals
Sanofi moves up opening of Singapore vaccine plant to 2025
Drugmaker ushers in 'the future' with modular production and AI
Coronavirus
Shionogi in talks with U.S. to supply COVID oral drug
Japanese drugmaker also says vaccine proven effective in trials
Trade
India's role in illicit synthetic drug trade draws closer scrutiny
Reports shed light on how cartels rely on supplies from across Asia
Pharmaceuticals
Eisai seeks accelerated FDA review of Alzheimer's drug
Quick approval sought despite Medicare's decision to limit coverage
Pharmaceuticals
The great medicines migration: How China controls key drug supplies
Western powers aim to reverse the industry's West-to-East shift
Pharmaceuticals
Takeda to give foreign directors two-thirds majority on board
Former U.S. EXIM Bank chief and veteran biotech exec nominated for seats
Pharmaceuticals
Eisai reboots search for blockbuster Alzheimer's drug
Failure to strike gold with Aduhelm prompts renewed focus on successor
COVID vaccines
Japan's Shionogi booster delivers similar results to Pfizer: study
Deliveries of COVID vaccine to start as early as May after trial success